Bjørn Tore Gjertsen Selected Research

Bjørn Tore Gjertsen Research Topics

Disease

49	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 06/2002
44	Neoplasms (Cancer) 05/2024 - 07/2003
17	Leukemia 01/2023 - 06/2002
9	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2024 - 06/2006
4	Pancreatic Neoplasms (Pancreatic Cancer) 11/2020 - 02/2014
3	Adenocarcinoma 10/2017 - 02/2014
3	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 04/2013
3	Cytopenia 07/2010 - 06/2002
2	Lymphoma (Lymphomas) 05/2024 - 12/2007
2	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2018
2	Circulating Neoplastic Cells 04/2021 - 09/2020
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 08/2013
2	Inflammation (Inflammations) 01/2021 - 04/2010
2	Philadelphia Chromosome 01/2020 - 01/2018
2	Glioblastoma (Glioblastoma Multiforme) 10/2019 - 01/2019
2	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 12/2012
2	Genetic Translocation (Chromosomal Translocation) 01/2018 - 12/2007
2	Ovarian Epithelial Carcinoma 01/2016 - 01/2014
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2013 - 03/2011
2	Lymphopenia (Lymphocytopenia) 01/2010 - 12/2008
2	Chromosome Aberrations (Chromosome Abnormalities) 05/2006 - 02/2002
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2006 - 02/2006
1	Prostatic Neoplasms (Prostate Cancer) 07/2023
1	Breast Neoplasms (Breast Cancer) 04/2023
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021
1	Premature Aging 01/2021
1	Multiple Sclerosis 01/2021
1	Melanoma (Melanoma, Malignant) 11/2019
1	Aggressive Fibromatosis (Desmoid) 06/2019

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2006
10	Valproic Acid (Depakote)FDA LinkGeneric 10/2019 - 01/2006
9	CytokinesIBA 05/2024 - 02/2005
9	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2019 - 01/2006
6	AntigensIBA 07/2023 - 09/2007
6	Histone Deacetylase InhibitorsIBA 01/2016 - 06/2006
5	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2018 - 06/2006
4	Tyrosine Kinase InhibitorsIBA 01/2024 - 06/2006
4	AntibodiesIBA 01/2022 - 09/2007
4	Protein Isoforms (Isoforms)IBA 01/2021 - 04/2006
4	ChemokinesIBA 06/2019 - 03/2007
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 02/2002
4	Phosphotransferases (Kinase)IBA 01/2018 - 02/2006
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2013
3	Gemcitabine FDA Link 02/2020 - 02/2014
3	Proteasome InhibitorsIBA 01/2019 - 06/2006
3	Tyrosine (L-Tyrosine)FDA Link 01/2018 - 02/2006
3	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 09/2014 - 02/2009
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 05/2014 - 02/2006
2	Dasatinib (BMS 354825)FDA Link 02/2024 - 01/2024
2	RNA (Ribonucleic Acid)IBA 01/2023 - 04/2013
2	VaccinesIBA 01/2023 - 01/2022
2	Trinitrotoluene (TNT)IBA 01/2020 - 01/2018
2	InterferonsIBA 01/2020 - 06/2019
2	nilotinib FDA Link 01/2020 - 01/2017
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 06/2006
2	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 01/2012
2	Bortezomib (Velcade)FDA Link 10/2019 - 01/2019
2	Sirolimus (Rapamycin)FDA Link 01/2018 - 03/2008
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2016 - 07/2013
2	Carboplatin (JM8)FDA LinkGeneric 01/2016 - 01/2014
2	Histones (Histone)IBA 05/2014 - 01/2012
2	Interleukin-6 (Interleukin 6)IBA 04/2010 - 01/2010
2	3-ingenyl angelateIBA 01/2010 - 06/2007
2	Protein Kinase CIBA 01/2010 - 06/2007
2	Complementary DNA (cDNA)IBA 03/2009 - 05/2006
2	Interleukin-8 (Interleukin 8)IBA 02/2005 - 04/2004
1	Chimeric Antigen ReceptorsIBA 05/2024
1	Human Papillomavirus Recombinant Vaccine nonavalentIBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Circulating Tumor DNAIBA 04/2021
1	ErbB Receptors (EGF Receptor)IBA 04/2021
1	Codon (Codons)IBA 01/2021
1	Macrophage Colony-Stimulating FactorIBA 01/2021
1	ProteomeIBA 01/2021
1	Plant ExtractsIBA 12/2020
1	Coloring Agents (Dyes)IBA 11/2020
1	fluorexon (calcein)IBA 11/2020
1	AnnexinsIBA 11/2020
1	Epithelial Cell Adhesion MoleculeIBA 09/2020
1	Immunoconjugates (Immunoconjugate)IBA 01/2020
1	bosutinibIBA 01/2020
1	Bevacizumab (Avastin)FDA Link 11/2019
1	Temozolomide (Temodar)FDA LinkGeneric 10/2019
1	Interferon-alpha (Interferon Alfa)IBA 07/2019
1	Peptides (Polypeptides)IBA 06/2019

Therapy/Procedure

32	Therapeutics 01/2022 - 04/2004
19	Drug Therapy (Chemotherapy) 01/2023 - 06/2002
7	Immunotherapy 07/2023 - 02/2006
4	Aftercare (After-Treatment) 04/2023 - 02/2002
3	Microbubbles 02/2020 - 12/2016
3	Stem Cell Transplantation 01/2018 - 06/2006
2	Induction Chemotherapy 01/2023 - 01/2023
2	Hematopoietic Stem Cell Transplantation 01/2023 - 01/2021
2	Precision Medicine 07/2022 - 01/2022
1	Cryosurgery 07/2023
1	Castration 07/2023
1	Lab-On-A-Chip Devices 09/2020
1	Injections 06/2019
1	Subcutaneous Injections 06/2019